Back to Journals » Cancer Management and Research » Volume 13

Change in Maximal Esophageal Wall Thickness Provides Prediction of Survival and Recurrence in Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy and Surgery

Authors Wu Y, Li J

Received 4 December 2020

Accepted for publication 16 February 2021

Published 15 March 2021 Volume 2021:13 Pages 2433—2445

DOI https://doi.org/10.2147/CMAR.S295646

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Editor who approved publication: Dr Ahmet Emre Eşkazan


Yahua Wu, Jiancheng Li

Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, Fujian, 350014, People’s Republic of China

Correspondence: Jiancheng Li
Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Jin’an District, Fuzhou, Fujian, 350014, People’s Republic of China
Tel +8613906900190
Email [email protected]

Purpose: This study aimed to evaluate the relationship of the percentage decrease of maximal esophageal wall thickness with pathological complete response (pCR) and recurrence in esophageal squamous cell carcinoma (ESCC).
Patients and Methods: A total of 146 ESCC patients treated with neoadjuvant chemoradiotherapy (NCRT) and surgery were included. The prognostic factors for overall survival (OS) and disease-free survival (DFS) were analyzed. The recurrence site, time, and frequency were included in the analysis. The percentage decrease of maximal esophageal wall thickness after NCRT was determined with the formula: [(pre-post)/pre] × 100.
Results: Overall, only 42 patients achieved pCR. Multivariable logistic analyses showed that the percentage decrease of maximal esophageal wall thickness (HR: 2.504; 95% CI: 1.112– 5.638, P=0.027) was independently correlated with pCR. In multivariable Cox analyses, a ≤ 40% percentage decrease of maximal esophageal wall thickness was an independent adverse factor for both OS (HR: 1.907, 95% CI: 1.149– 3.165; P=0.012) and DFS (HR: 2.054, 95% CI: 1.288– 3.277; P=0.003). Compared with patients with a ≤ 40% percentage decrease, those with a > 40% percentage decrease had better 5-year OS (29.0% vs 60.1%, P< 0.05) and DFS (27.8% vs 54.4%, P< 0.05). Perineural invasion (PNI) was also an unfavorable factor for OS (HR: 2.138, 95% CI: 0.094– 4.178; P=0.026). Lymph vessel invasion (HR: 2.874, 95% CI: 1.574– 5.248; P=0.001) and PNI (HR: 2.050; 95% CI: 1.044– 4.023; P=0.037) were independent prognosticators for DFS. The rates of local and distant recurrence were also significantly difference between those with a percentage decrease of ≤ 40% and of > 40% (P< 0.05).
Conclusion: The percentage decrease of maximal esophageal wall thickness is associated with pCR and recurrence in ESCC patients who undergo NCRT and surgery and can thus be used to independently predict prognosis.

Keywords: neoadjuvant, esophageal squamous cell carcinoma, esophageal wall thickness, pathological complete response, recurrence

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]